Table 1: Characteristics of the study groups and serum cytokeratin-18/M30 antigen levels.
| Control Group (n = 27) | IGT Group (n = 27) | Type 2 Diabetes Group (n = 44) | |
|---|---|---|---|
| Age (year) | 53 (35-66) | 50 (19-77) | 56 (37-74) |
| BMI (kg/m2) | 28 (24-32) | 30 (24-48) | 29 (17-42) |
| Sistolic Pressure (mm/Hg) | 12(9-14) | 12 (9-16) | 13 (11-20) |
| Diastolic Pressure (mm/Hg) | 7(5-9) | 8 (5-9) | 8 (6-10) |
| Total Cholesterol (mg/dL) | 180(98-200) | 192 (100-259) | 177 (104-266) |
| Triglyceride (mg/dL) | 115(34-201) | 121 (43-312) | 112 (21-228) |
| HDL (mg/dL) | 49(36-73) | 45 (33-64) | 47 (32-71) |
| LDL (mg/dL) | 115(48-153) | 115 (44-162) | 111 (53-201) |
| Fasting glucose (mg/dL) | 88 (71-101)a | 100 (86-124)b | 111 (84-195) |
| c-Peptide (ng/mL) | 3.38 (1.20-8.40)c | 3.30 (0.81-8.64) | 3.21 (1.41-6.20) |
| HbA1c (%) | 5.3 (4.8-5.9)a | 6.0 (4.8-6.9)d | 6.4 (5.5-9.0) |
| Cytokeratin-18/M30 antigen (U/L) | 135 (10-510) | 182 (75-950)e | 170 (10-1000) |
aP < 0.001 versus Type 2 Diabetes Group and IGT Group, bP < 0.005 versus Type 2 Diabetes Group, cP < 0.05 versus Type 2 Diabetes Group, dP < 0.01 versus Type 2 Diabetes Group, eP < 0.05 versus Control Group.